Oriza Seed Leads $25M Round In Chinese Healthcare Company EpimAb Biotherapeutics

This Data Is Locked!

This area is available only to Subscribers.

Oriza Seed Venture Capital, an early stage investment unit under Oriza Holdings, has led a US$25 million series A round in EpimAb Biotherapeutics, a Shanghai-based... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?